|
Volumn 57, Issue 1, 2008, Pages 51-53
|
What is the most effective and safe malaria prophylaxis during pregnancy?
a a b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMALARIAL AGENT;
ARTESUNATE;
ATOVAQUONE PLUS PROGUANIL;
CHLOROQUINE;
CHLOROQUINE PLUS PROGUANIL;
DOXYCYCLINE;
FANSIDAR;
MEFLOQUINE;
PRIMAQUINE;
QUININE;
ANEMIA;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HYPOGLYCEMIA;
INCIDENCE;
INFECTION RISK;
INTRAVASCULAR HEMOLYSIS;
JAUNDICE;
KERNICTERUS;
LOW BIRTH WEIGHT;
MALARIA;
MENTAL DISEASE;
MOUTH ULCER;
NOTE;
PERINATAL DEATH;
PLASMODIUM;
PREGNANCY;
PRURITUS;
STEVENS JOHNSON SYNDROME;
TERATOGENICITY;
TOXIC EPIDERMAL NECROLYSIS;
CHEMOPROPHYLAXIS;
CONGENITAL MALFORMATION;
PRACTICE GUIDELINE;
PREGNANCY COMPLICATION;
REVIEW;
ABNORMALITIES, DRUG-INDUCED;
ANTIMALARIALS;
CHEMOPREVENTION;
CHLOROQUINE;
DOXYCYCLINE;
FEMALE;
HUMANS;
MALARIA;
MEFLOQUINE;
PRACTICE GUIDELINES AS TOPIC;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
|
EID: 38549166266
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (5)
|
References (7)
|